Oral zinc sulphate as primary therapeutic intervention in a child with Wilson disease

Eur J Pediatr. 1989 Jun;148(7):654-5. doi: 10.1007/BF00441526.

Abstract

An 8-year-old boy with an hepatic form of Wilson disease was treated with oral zinc sulphate as the primary and sole therapy. After 4 months, liver function had dramatically improved, and the parameters characterizing copper metabolism had also normalized.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Child
  • Copper / physiology
  • Hepatolenticular Degeneration / drug therapy*
  • Humans
  • Male
  • Sulfates / administration & dosage
  • Zinc / administration & dosage*

Substances

  • Sulfates
  • Copper
  • Zinc